Stock Rating Downgrade
In the last week the Value Trend Rating for Integra LifeSciences Holdings Co (NASDAQ: IART) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
Integra LifeSciences Holdings Co (NASDAQ: IART) stock closed at $24.78 on 11/8/24 after a decline of -2.9%. This decline was accompanied by normal trading volume. The stock has risen 32.1% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, IART is expected to continue to be an important Value Builder.
Integra LifeSciences Holdings has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Integra LifeSciences Holdings has a good Appreciation Score of 73 but a very low Power Rating of 4, triggering the Negative Value Trend Rating.
Be the first to comment